EC

Endocrine-related Cancer

Endocrine-Related Cancer is a journal focused on endocrine-related cancer research. It publishes accepted manuscripts and special collections, has a 2024 Journal Impact Factor of 4.6 and a CiteScore of 8.1, and is available in print and online editions with ISSNs 1351-0088 and 1479-6821.

Looking to publish in Endocrine-related Cancer? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Endocrinology & Metabolism, Oncology
Impact Factor 4.6
Quartile Q1
Open Access Type Hybrid
ISSN 1351-0088
eISSN 1479-6821
Invitation Only No
Cost Range Gold open access APC: £3000; £1500 for non-profit subscribers. Green open access is free. Corresponding authors at institutions with a Read and Publish deal may qualify for free gold open-access publication.

Submission Instructions

Endocrine-related Cancer accepts the following article types. Click on an article type to view submission instructions.

Research Articles

Cover Letter Research Articles must include statements on conflicts of interest, funding, and acknowledgements or author contributions in the separate title page document rather than the anonymised main manuscript.
Abstract Research Articles must include an abstract. The abstract must be a single paragraph of no more than 250 words. The abstract must be unstructured as a single paragraph. The abstract must state the study objective, methods where applicable, and summarise results and conclusions without using abbreviations or references.
Manuscript Research Articles are limited to 6,000 words unless otherwise specified. Research Articles must include the sections Title Page, Abstract, Introduction, Materials and methods, Results, Discussion, Declaration of interest, Funding and Acknowledgements, References, Tables, and Figures. Research Articles must include at least four keywords, a generative AI disclosure statement, and a Data Availability Statement.
References Research Articles should contain no more than 60 references. References must be cited numerically in Vancouver style. References must be listed in citation order and include at least three authors before 'et al.' is used.
Figures & Tables Manuscripts should contain no more than 10 figures, and large tables should be submitted as supplementary materials. The title page must be uploaded separately from the anonymised main manuscript. Figures and tables must be anonymised, numbered in the order cited, and accompanied by legends or titles.
Reformat to Endocrine-related Cancer using Livewrite Premium

Reviews

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract requirements are not specified.
Manuscript Reviews must be limited to 6,000 words. Reviews should include the sections used in the Preparation of Manuscripts guidance. The manuscript must include a generative AI disclosure statement, including the specified no-use statement if no generative AI tools were used.
References Reviews must have a maximum of 60 references. References must be cited numerically in Vancouver style. References must be listed in the order cited in the text, and at least three authors must be listed before using 'et al.'.
Figures & Tables Reviews must have a maximum of 10 figures and tables. Figures and tables must be anonymised and must not include any reference to author affiliations.
Reformat to Endocrine-related Cancer using Livewrite Premium

Mini Reviews

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract requirements are not specified.
Manuscript Mini Reviews must be no more than 3000 words in length. A statement disclosing whether generative AI was used must be included in the manuscript, and if none was used it must state: “No generative Artificial Intelligence (AI) tools were used in the preparation of the written or visual content of this manuscript.”
References Mini Reviews must have 30 references. References must be cited numerically in Vancouver style. References must be listed in the order cited in the text and include at least three authors before using 'et al.'.
Figures & Tables Mini Reviews must have 5 figures.
Reformat to Endocrine-related Cancer using Livewrite Premium

Systematic Reviews

Cover Letter Cover Letter requirements are not specified.
Abstract Systematic Reviews must include an abstract. The abstract must not exceed 250 words. The abstract must be structured. The abstract must use the headings Purpose, Methods, Results and Conclusions.
Manuscript Systematic Reviews must be limited to 6,000 words. The manuscript must include Title page, Abstract, Introduction, Materials and Methods, Results, Discussion, Declaration of interest, Funding and Acknowledgments, Data sharing or availability statement, References, Tables, and figures. The abstract and Materials and Methods section should include a statement confirming adherence to PRISMA, and the manuscript must include a generative AI use statement.
References References should not exceed 60. References must be cited in Vancouver style. References must be numbered in citation order and list at least three authors before using 'et al.'.
Figures & Tables Figures should not exceed 10. The title page must be uploaded separately, but no explicit placement rule is stated for figures and tables. Tables and figures must be numbered in the order they are cited in the text, and figures, tables, and legends must not include author affiliations.
Reformat to Endocrine-related Cancer using Livewrite Premium

Clinical Review: Approach To Patient With Endocrine Tumour

Cover Letter Cover Letter requirements are not specified.
Abstract An abstract is required. Abstract must be up to 250 words.
Manuscript Manuscript must be up to 5000 words. Manuscript must include the sections Introduction, Future directions, Conclusion, and References, and the Introduction must cover disease overview and clinical significance. Manuscript must include a statement disclosing whether generative AI was used in preparing the written or visual content, and if none was used it must state that no generative Artificial Intelligence tools were used.
References References must not exceed 60. References must be cited numerically in Vancouver style. References must be listed in the order cited in the text, all cited references must appear in the reference list and vice versa, web-only sources must be cited in the text with access date and omitted from the reference list, unpublished work must be cited only in the text, and at least three authors must be listed before using 'et al.'.
Figures & Tables There must be no more than 6 figures or tables. Figures and tables must be numbered in the order cited in the text and must not include any reference to author affiliations.
Reformat to Endocrine-related Cancer using Livewrite Premium

Letters To The Editor

Cover Letter A formal proposal must be submitted to the editorial office before submission and must include a proposed outline, a brief explanation of timeliness and value to the current literature, a brief explanation of relevance to readers, and a one- or two-page CV and publication record for the past 5 years for all authors or valid ORCID IDs with publication histories updated for at least the past 5 years.
Abstract Abstract is not allowed for Letters To The Editor.
Manuscript Letters To The Editor must be no longer than 1500 words. Letters To The Editor must comment on papers published in this journal within the last 12 months and be written in a neutral tone. The manuscript must include a generative AI use statement, and supplementary data is not allowed.
References Letters To The Editor must have no more than 10 references. References must be cited numerically in Vancouver style. References must be listed in the order cited in the text and must list at least three authors before using 'et al.'.
Figures & Tables Letters To The Editor must have no figures or tables.
Reformat to Endocrine-related Cancer using Livewrite Premium

Case Reports

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract requirements are not specified.
Manuscript Manuscript must not exceed 6,000 words. Manuscript must include a statement disclosing whether generative AI was used, and if used must list the name, version, model, and source, or otherwise state that no generative AI tools were used in preparing the written or visual content.
References Reference list should contain no more than 60 references. References must be cited numerically in Vancouver style. References must be listed in the order cited in the text, all text citations and reference-list entries must correspond, and at least three authors must be listed before using 'et al.'.
Figures & Tables Manuscript should contain no more than 10 figures. Figures and tables must be numbered in the order they are cited in the text, and figures, tables, and legends must not include any reference to author affiliations.
Reformat to Endocrine-related Cancer using Livewrite Premium

Case Series

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract requirements are not specified.
Manuscript Manuscript must not exceed 6,000 words. Manuscript must include a statement disclosing whether generative AI was used in preparing the written or visual content, and if none was used it must state: “No generative Artificial Intelligence (AI) tools were used in the preparation of the written or visual content of this manuscript.”
References Reference list should contain no more than 60 references. References must be cited numerically in Vancouver style. References must be listed in citation order and include at least three authors before using 'et al.'.
Figures & Tables Manuscript should contain no more than 10 figures. Figures and tables must be numbered in the order they are cited in the text, and figures, tables, and legends must not include any reference to author affiliations.
Reformat to Endocrine-related Cancer using Livewrite Premium

Endocrine Tumour In Focus

Cover Letter Cover Letter requirements are not specified.
Abstract An abstract is required. Abstract must be no more than 200 words.
Manuscript Manuscript must be no more than 4000 words. Manuscript must include the sections Introduction, Knowledge gaps and future directions, Conclusion, and References. Manuscript must include a statement disclosing whether generative AI was used, and if not used it must state: “No generative Artificial Intelligence (AI) tools were used in the preparation of the written or visual content of this manuscript.”
References Reference list must contain no more than 40 references. References must be cited numerically in Vancouver style. References must be listed in the order cited in the text and must list at least three authors before using 'et al.'.
Figures & Tables Manuscript must have no more than 4 figures or tables. Figures and tables must be numbered in the order they are cited in the text and must not include any reference to author affiliations.
Reformat to Endocrine-related Cancer using Livewrite Premium

Guidelines And Recommendations

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract requirements are not specified.
Manuscript Manuscripts must be limited to 6,000 words. Manuscripts must clearly describe the authors’ and society’s roles, the literature search and review approach with dates and consistency, a DELPHI-based consensus method, and evidence quality assessment and scoring for the final recommendations. Manuscripts must include a generative AI disclosure statement and should clearly delineate the recommendation scoring system and approach, preferably with a table.
References Manuscripts should contain no more than 60 references. References must be cited numerically in Vancouver style. References must be listed in the order cited in the text, with at least three authors named before using 'et al.'.
Figures & Tables Manuscripts should contain no more than 10 figures. Figures and tables must be numbered in the order they are cited in the text, and figures, tables, and legends must not include any reference to author affiliations.
Reformat to Endocrine-related Cancer using Livewrite Premium

Recent Publications

The Role of Stem Cells in Pituitary Tumour Formation

James Kaufman-Cook, Bence Kövér, Cynthia L. Andoniadou

10.1530/erc-26-0171
View Publication

Hormone secretion predicts poor prognosis in lung neuroendocrine neoplasms

Ieva Lase, Eir Löfgren, Agnes Hegedus, Malin Grönberg, Staffan Welin, Eva Tiensuu Janson

10.1530/erc-26-0142
View Publication

B7-H3 (CD276) as a Candidate Therapeutic Target in Medullary Thyroid Cancer

Teresa Binter, Erwin Tomasich, Philipp Melhorn, Peter Mazal, Philipp Riss, Christian Scheuba, Anna Bergmeister-Berghoff, Markus Raderer, Barbara Kiesewetter

10.1530/erc-26-0241
View Publication

Molecular determinants of AR-enhancer interaction and cistrome reprogramming in prostate cancer progression

Rayzel C. Fernandes, Kyle K. Greenland, Moray J. Campbell, Charlotte L. Bevan

10.1530/erc-25-0529
View Publication

Is preoperative adrenoceptor blockade necessary in patients with paraganglioma?

Anna Angelousi, Eleni Memi, George N Zografos, Eleftherios Chatzellis, Eva Kassi, Gregory Kaltsas

10.1530/erc-26-0007
View Publication

Frequently asked questions

How long does it take to publish?

On average the journal returns a decision on a peer-reviewed paper in 18 days.

Reformat to Endocrine-related Cancer using Livewrite Premium

Is a cover letter required?

A cover letter should introduce the paper and explain why the work is important and suitable for publication at this time.

Reformat to Endocrine-related Cancer using Livewrite Premium

What are the publication costs?

Gold open access APC is £3000 for Endocrine-Related Cancer, with a £1500 rate for non-profit subscribers. Green open access is free. Authors at institutions with a Read and Publish deal may qualify for free gold open-access publication.

Reformat to Endocrine-related Cancer using Livewrite Premium

Research Topics

Neuroendocrine Tumor Research Advances Thyroid Cancer Diagnosis and Treatment Estrogen and related hormone effects Adrenal and Paraganglionic Tumors Cancer, Hypoxia, and Metabolism Neuroblastoma Research and Treatments Prostate Cancer Treatment and Research Pituitary Gland Disorders and Treatments Lung Cancer Research Studies Cancer-related Molecular Pathways Growth Hormone and Insulin-like Growth Factors Metabolism, Diabetes, and Cancer HER2/EGFR in Cancer Research Hormonal Regulation and Hypertension Pancreatic and Hepatic Oncology Research BRCA gene mutations in cancer Cancer Risks and Factors Cancer Cells and Metastasis PI3K/AKT/mTOR signaling in cancer Cancer, Lipids, and Metabolism Breast Cancer Treatment Studies Thyroid Disorders and Treatments Glioma Diagnosis and Treatment Epigenetics and DNA Methylation Cytokine Signaling Pathways and Interactions

Related Journals

CN
Cancer Nanotechnology BioMed Central
NR
Nature Reviews Endocrinology NATURE PORTFOLIO
BE
Biochimica Et Biophysica Acta-reviews On Cancer Elsevier BV
JO
Journal Of Mammary Gland Biology And Neoplasia Springer Science+Business Media
D&
Diabetes & Metabolic Syndrome-Clinical Research & Reviews Elsevier BV
JO
Journal Of Neuroendocrinology WILEY